110 related articles for article (PubMed ID: 22525211)
1. Fatal pneumonia associated with temozolomide therapy in patients with malignant glioma.
Hayashi H; Saito Y; Kokuho N; Morimoto T; Kobayashi K; Tanaka T; Abe S; Fujita K; Azuma A; Gemma A
Jpn J Clin Oncol; 2012 Jul; 42(7):632-6. PubMed ID: 22525211
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas.
De Vos FY; Gijtenbeek JM; Bleeker-Rovers CP; van Herpen CM
Crit Rev Oncol Hematol; 2013 Mar; 85(3):373-82. PubMed ID: 22925496
[TBL] [Abstract][Full Text] [Related]
3. A fatal case of acute interstitial pneumonia (AIP) in a woman affected by glioblastoma.
Balzarini L; Mancini C; Marvisi M
Curr Drug Saf; 2014 Mar; 9(1):73-6. PubMed ID: 24410308
[TBL] [Abstract][Full Text] [Related]
4. Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma.
Yaman E; Coskun U; Ozturk B; Buyukberber S; Kaya AO; Coskun O; Buyukberber N; Yildiz R; Benekli M
J Clin Neurosci; 2009 Apr; 16(4):591-2. PubMed ID: 19201195
[TBL] [Abstract][Full Text] [Related]
5. Patients receiving standard-dose temozolomide therapy are at risk of Pneumocystis carinii pneumonia.
Yu SK; Chalmers AJ
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):631-2. PubMed ID: 17644327
[No Abstract] [Full Text] [Related]
6. A case of pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma.
Saito Y; Nagayama M; Miura Y; Ogushi S; Suzuki Y; Noro R; Minegishi Y; Kimura G; Kondo Y; Gemma A
Jpn J Clin Oncol; 2013 May; 43(5):559-62. PubMed ID: 23423809
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide-associated organizing pneumonitis.
Maldonado F; Limper AH; Lim KG; Aubrey MC
Mayo Clin Proc; 2007 Jun; 82(6):771-3. PubMed ID: 17550757
[TBL] [Abstract][Full Text] [Related]
8. Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia.
Matsumura Y; Ito Y; Yamamoto M; Matsushima A; Nagao M; Takakura S; Iinuma Y; Ichiyama S
J Infect Chemother; 2014 Feb; 20(2):109-14. PubMed ID: 24480550
[TBL] [Abstract][Full Text] [Related]
9. Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide.
Ganière V; Christen G; Bally F; Guillou L; Pica A; de Ribaupierre S; Stupp R
Nat Clin Pract Oncol; 2006 Jun; 3(6):339-43; quiz following 343. PubMed ID: 16757971
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis jirovecii pneumonia complicating the progress of a patient with glioblastoma multiforme receiving temozolomide.
Gorospe Sarasúa L; Ureña-Vacas A; Muñoz Del Toro JR
Arch Bronconeumol; 2016 Oct; 52(10):534-5. PubMed ID: 27021139
[No Abstract] [Full Text] [Related]
12. Unusual and severe symptomatic impairment of neutrophil function after one cycle of temozolomide in patients with malignant glioma.
Hartmann P; Herholz K; Salzberger B; Petereit HF
Ann Hematol; 2004 Apr; 83(4):212-7. PubMed ID: 14648028
[TBL] [Abstract][Full Text] [Related]
13. An Australian experience with temozolomide for the treatment of recurrent high grade gliomas.
Harris MT; Rosenthal MA; Ashley DL; Cher L
J Clin Neurosci; 2001 Jul; 8(4):325-7. PubMed ID: 11437571
[TBL] [Abstract][Full Text] [Related]
14. Food and Drug Administration Drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme.
Cohen MH; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6767-71. PubMed ID: 16203762
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Pneumocystis jirovecii pneumonia after temozolomide for CNS malignancies without prophylaxis.
Neuwelt AJ; Nguyen TM; Fu R; Bubalo J; Tyson RM; Lacy C; Gahramanov S; Nasseri M; Barnes PD; Neuwelt EA
CNS Oncol; 2014 Jul; 3(4):267-73. PubMed ID: 25286038
[TBL] [Abstract][Full Text] [Related]
16. Is protracted low-dose temozolomide feasible in glioma patients?
Wong ET
Neurology; 2006 Aug; 67(3):543-4; author reply 543-4. PubMed ID: 16894133
[No Abstract] [Full Text] [Related]
17. Phase I trial of temozolomide using an extended continuous oral schedule.
Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
[TBL] [Abstract][Full Text] [Related]
18. Is protracted low-dose temozolomide feasible in glioma patients?
Tosoni A; Cavallo G; Ermani M; Scopece L; Franceschi E; Ghimenton C; Gardiman M; Pasetto L; Blatt V; Brandes AA
Neurology; 2006 Feb; 66(3):427-9. PubMed ID: 16476947
[TBL] [Abstract][Full Text] [Related]
19. Rapid desensitization with temozolomide in patients with delayed maculopapular rash.
Alonso-Llamazares A; Vega-Castro A; Beitia-Mazuecos JM; Mateo-Borrega B; Cardenas-Contreras R
J Investig Allergol Clin Immunol; 2012; 22(6):448-9. PubMed ID: 23101195
[No Abstract] [Full Text] [Related]
20. Intracerebral hemorrhage secondary to thrombocytopenia in a patient treated with temozolomide.
Sure D; Dunn I; Norden A; Anderson WS
Clin Neurol Neurosurg; 2010 Oct; 112(8):741-2. PubMed ID: 20434832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
